2004
DOI: 10.1289/ehp.112-a151
|View full text |Cite
|
Sign up to set email alerts
|

Study Criticisms Unjustified

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2009
2009
2010
2010

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Some scientists and activist groups challenged the ethical and scientific validity of the studies, contending among other things that people should not be put at risk for the purpose of reducing the stringency of regulatory standards [3,6,8,11,12]. Other scientists and industry groups argued that the human dosing studies were needed to ensure the scientific quality and accuracy of EPA's safety evaluations and that they had been and could be conducted ethically [4,5,10,26,27]. In response to the controversy, EPA commissioned the National Academy of Sciences to advise whether and under what circumstances the Agency should consider and accept intentional human dosing studies.…”
Section: Review Findingsmentioning
confidence: 99%
See 1 more Smart Citation
“…Some scientists and activist groups challenged the ethical and scientific validity of the studies, contending among other things that people should not be put at risk for the purpose of reducing the stringency of regulatory standards [3,6,8,11,12]. Other scientists and industry groups argued that the human dosing studies were needed to ensure the scientific quality and accuracy of EPA's safety evaluations and that they had been and could be conducted ethically [4,5,10,26,27]. In response to the controversy, EPA commissioned the National Academy of Sciences to advise whether and under what circumstances the Agency should consider and accept intentional human dosing studies.…”
Section: Review Findingsmentioning
confidence: 99%
“…The critique further pointed out that the lack of power in the study would invalidate any inferences for or against a NOAEL. In response, Chart and colleagues [4] disputed the biological significance of the modest cholinesterase decline since a) no clinical effects were seen and b) the decline was said to provide evidence of exposure, but was too small to indicate hazard. With regard to the power issue, Chart et al acknowledged the relatively small study size, but pointed to an overall database of hundreds of animal and human studies with dichlorvos, arguing that the available health data on any given substance should be evaluated as a whole in risk assessments.…”
Section: Review Findingsmentioning
confidence: 99%